Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
United Kingdom
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
France
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Spain
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Germany
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Czech Republic
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Switzerland
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Belgium
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
Austria
12710856.1
Filed on 2012-03-21
12710856.1
Filed on 2012-03-21
Anti-Epidermal Growth Factor Receptor Variant III Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer
European Patent
18188913.0
Filed on 2018-08-14
18188913.0
Filed on 2018-08-14
MURINE ANTI-NY-ESO-1 T CELL RECEPTORS
US Patent 10,407,485
Filed on 2018-08-29
Filed on 2018-08-29